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While Onyx embolization of cerebrospinal arteriovenous shunts is well-es-
tablished, clinical researchers continue to broaden applications to other 
vascular lesions of the neuraxis. This report illustrates the application of 
Onyx (eV3, Plymouth, MN) embolization to vertebral body lesions, specifi-
cally, a vertebral hemangioma and renal cell carcinoma vertebral body 
metastatic lesion.
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INTRODUCTION
Hypervascular bone metastases and vascular spinal 
tumors can cause high volume blood loss during 
open surgery.2)3)6) Presurgical embolization of these le-
sions decreases intraoperative blood loss and facili-
tates subsequent surgical resection.7)15)19) Agents used 
for embolization of tumors include polyvinyl alcohol 
(PVA), gelfoam powder, fibrin glue, gelatin micro-
spheres, liquid adhesives, alcohol and coils.4)11) Until 
recently, PVA particle embolization has served as the 
mainstay of embolization.4)11) Onyx (eV3, Plymouth, 
MN, USA) is a nonpolymerizing liquid agent com-
posed of ethylene-vinyl alcohol copolymer dissolved 
in dimethyl sulfoxide. When injected, Onyx precip-
itates within vessels forming a spongy cast. We report 
the use of Onyx in the embolization of vertebral body 
lesions, including a renal cell carcinoma vertebral 
body metastatic lesion and a vertebral hemangioma.
CASE REPORTS
Case 1
A 74-year-old male patient with ongoing persistent 
lower lumbar spine pain, shortness of breath, and 
cough was initially treated symptomatically for his 
pain and for presumed pneumonia. Computed to-
mography (CT) demonstrated an 11 mm right middle 
lobe lesion and an indeterminate 13 mm right adrenal 
lesion, prompting further evaluation with positron 
emission tomography (PET)-CT. A PET-CT demon-
strated a fluorodeoxyglucose (FDG)-avid left renal 
mass suggestive of malignancy with an associated L2 
vertebral body and left humeral head destructive 
lesion. He underwent total spine magnetic resonance 
imaging (MRI) and lumbar spine CT imaging, reveal-
ing a large destructive L2 vertebral body lesion with 
a pathologic fracture and 4-mm soft tissue extension 
into the ventral spinal canal, resulting in moderate 
left-sided spinal canal narrowing (Fig. 1). Significant 
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Fig. 2. Selective angiography of the left L2 segmental artery demonstrates a significant pathologic vascular blush at the level of the 
L2 vertebral body (A). Post-embolization unsubtracted radiograph shows Onyx distributed diffusely through the lateral vertebral body 
(B). Post-embolization selective left L2 segmental artery injection demonstrates grossly total angiographic devascularization of the L2 
vertebral body tumor (C).
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Fig. 1. Axial noncontrast lumbar spine computed tomography (A) and sagittal reformat (B) show a destructive L2 lesion with ex-
tension into the left pedicle and large epidural soft tissue component causing moderate spinal canal stenosis. There is pathologic 
compression with at least 50% loss of height centrally. Axial (C) and sagittal (D) T2 magnetic resonance images demonstrate a large 
destructive L2 lesion with pathologic fracture and 4 mm soft tissue extension into the ventral spinal canal, resulting in moderate left 
sided spinal canal narrowing.
L2-L3 left subarticular zone, neural foraminal narrow-
ing, and compression on the left traversing L3 and ex-
iting L2 nerve roots were also identified. There was 
no cord compression or signal abnormality. The pa-
tient was referred for embolization prior to planned 
surgical resection.
The patient was placed under general anesthesia 
and standard access with a 5 French sheath in the 
common femoral artery was achieved. A 5 French 
Mickelson catheter (Cook Medical Inc., Bloomington, 
IN, USA) was employed to selectively catheterize the 
left L2 segmental artery and an angiographic run 
demonstrated an obvious pathologic blush in the re-
gion of the L2 vertebral body (Fig. 2A). Opacification 
of a spinal pial artery (artery of Adamkiewicz) was 
not seen. An Echelon microcatheter (eV3, Plymouth, 
MN, USA) was advanced through the Mickelson cathe-
ter (Cook Medical Inc., Bloomington, IN, USA) into the 
distal left L2 segmental artery and Onyx-18 (eV3, 
Plymouth, MN, USA) was injected, creating a cast 
within the segmental artery. The injected Onyx-18 
was allowed to reflux into the vertebral body until 
the metastatic lesion was completely embolized (Fig. 
2B-C). A total volume of 0.64 milliliters (mL) of Onyx 
was used. Subsequent selective injection of the right 
L2 segmental artery demonstrated minimal pathologic 
blush. The total fluoroscopy time for the procedure 
was 33 minutes, and the procedural duration was 2.5 
hours. Post-procedure plain X-ray films confirmed 
Onyx distribution in the left half of the vertebral 
body, within the tumor (Fig. 3). The patient sub-
sequently underwent an uneventful corpectomy and 
fusion with minimal blood loss (less than 100 cc) and 
recovered without complications.
Case 2
A 52-year-old male patient presented with six 
months of progressive bilateral lower extremity weak-
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Fig. 3. Postembolization frontal (A) and lateral (B) lumbar spine radiographs show penetration of Onyx through tumor vessels within 
the L2 vertebral body. Reflux into the epidural venous plexus is seen.
ness and worsening sensory function, leading to mul-
tiple falls. There were also spasms and spasticity of 
the lower extremities bilaterally, and several episodes 
of fecal and urinary incontinence. A CT and total 
spine MRI revealed multiple lesions with coarse tra-
beculae in the thoracic (T1, T3 and T11) and lumbar 
spine (L1), most severe within the T3 vertebral body. 
These lesions extended to the posterior elements and 
soft tissues in the surrounding paravertebral and epi-
dural space, causing significant anterior cord com-
pression (Fig. 4). 
An open biopsy confirmed an intraosseous he-
mangioma, and the patient was referred for emboliza-
tion prior to anticipated surgical resection. The patient 
was placed under general anesthesia and standard ac-
cess with a 5 French sheath in the common femoral 
artery was achieved. The right T4 segmental artery 
was selectively catheterized with a Cobra catheter 
(Terumo, Somerset, NJ, USA). Angiography demon-
strated a large pathologic blush in the region of the 
T3 vertebral body, corresponding to the known he-
mangioma (Fig. 5A). Opacification of a spinal pial ar-
tery was not seen. An Echelon microcatheter was ad-
vanced into the segmental artery and the vascular 
supply to the hemangioma was embolized with a to-
tal of 0.24 mL of Onyx-18 (Fig. 5B). The procedural 
total fluoroscopy time was 27 minutes, and proce-
dural duration was 2.5 hours. Post-embolization an-
giography via the Cobra catheter confirmed no fur-
ther pathologic blush (Fig. 5C, Fig. 6). The patient re-
covered uneventfully from the embolization and sur-
gical resection, the latter with 300 cc of estimated 
blood loss. 
DISCUSSION 
Metastatic disease occurs in approximately 30% to 
50% of patients with renal cell carcinoma at the time 
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Fig. 4. Axial computed tomography demonstrates a hypodense 
lesion with coarse trabeculae within the T3 vertebral body with 
extensive soft tissue in the surrounding paravertebral and epi-
dural space causing significant anterior cord compression (A). 
Sagittal T2-weighted (B) and Short T1 Inversion Recovery (STIR) 
(C) magnetic resonance images of thoracic spine demonstrate a 
heterogeneous lesion at the T3 vertebral body extending later-
ally and posteriorly through the vertebral body and causing se-






Fig. 5. Selective angiography of the right T4 segmental artery demonstrates a pathologic blush in the region of the T3 vertebral 
body (A). Intraprocedural unsubtracted antero-posterior radiograph demonstrates Onyx distributed through the known T3 hemangio-
ma (B). Post-embolization selective injection of the right T4 segmental artery demonstrates no residual opacification of the pathologic 
vascular blush (C).
of initial diagnosis.9)15)16)18) Approximately 40% of pa-
tients develop bone metastases.11) In addition to 
drug-based therapies such as bisphosphonates and 
denosumab for the treatment of osseous metastatic le-
sions, radiation therapy and surgery are important in 
the treatment of renal cell carcinoma bone metastases.18) 
These interventions are considered appropriate when 
there is mechanical instability, intractable pain, radicul-
opathy and pathologic fractures.11)13)15)18) Surgical decom-
pression and stabilization are the treatments of choice 
for radiation resistant metastatic spinal tumors.11)13)14) 
Renal cell metastases to the vertebral bodies are, how-
ever, highly vascular and can cause life threatening 
bleeding.11)14)15) 
Vertebral hemangiomas are also highly vascular in-
traosseous lesions, thought to occur in approximately 
10% of all patients, most commonly in the thoracic 
and lumbar spine.5)6)10)17) These lesions are typically 
asymptomatic though they may enlarge, causing pain 
and neurological deficits secondary to spinal cord 
compression or pathological fractures.1)8) 
Multiple studies have demonstrated safe and effective 
results from preoperative embolization of both spinal 
metastases of renal origin and vertebral hemangiomas. 
Sundarasean et al. demonstrated successful results in 
the treatment of 17 patients who underwent selective 
spinal angiography and preoperative embolization 
with absolute ethyl alcohol in the treatment of spinal 
metastases.15) In 1999, Berkfield et al. verified the ef-
fectiveness of particle embolization, PVA, in reducing 
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Fig. 6. Postembolization axial noncontrast computed tomography (A) and coronal reformat (B) show penetration of Onyx through 
tumor vessels within the T3 vertebral body.
perioperative hemorrhage prior to corporectomy in 
hypervascular spinal tumors.2) Smith et al. demon-
strated the safety and effectiveness of transarterial 
embolization of symptomatic vertebral hemangiomas 
in eight cases using PVA.12) In 2013, Yao et al. de-
scribed four cases of transpedicular n-butyl cyanoa-
crylate (NBCA) direct-puncture embolization of spinal 
hemangiomas as a preoperative adjunct, facilitating 
resection of these high vascular tumors.19)
Cases reporting the use of Onyx for preoperative 
embolization of spinal tumors are limited. Hurley et 
al. were the first to document the use of Onyx, trans-
arterially, in the treatment of two cases of aggressive 
vertebral hemangiomas.6) Additional studies report 
use of Onyx via an arterial route and by direct punc-
ture in the treatment of hypervascular head, neck and 
spinal tumors.4) Advantages of Onyx embolization in-
clude a more controlled injection due to gradual pre-
cipitation in a centripetal fashion, allowing for slower 
and more accurate injections as well as penetration of 
very small caliber vessels.4) In addition, it can be easi-
ly visualized during surgery via intraoperative X-rays 
and directly visualized, serving as a roadmap for the 
surgeon.  
As is done during particulate embolization, careful 
attention must be paid to the initial diagnostic angio-
graphic run prior to embolization to ensure opacifica-
tion of a spinal pial artery such as the artery of 
Adamkiewicz is not seen. In both of our illustrative 
cases, this was not seen and embolization proceeded 
uneventfully without complication. Notably, as is il-
lustrated in Fig. 3, reflux of Onyx into the epidural 
venous plexus may occur without resultant morbidity. 
Our results further the growing body of literature 
confirming the safety and efficacy of Onyx emboliza-
tion of vertebral body lesions.
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